Cullinan Oncology LLC
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.7% | -1.3% | +1.3% | -1.3% | +1.3% | -1.3% | +1.3% | – | – | +0.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.0% | -12.1% | +18.3% | -2.1% | +14.0% | +2.4% | +47.2% | -31.2% | +2.3% | -1.9% | +5.5% | – | |
| – | -3.1% | +16.0% | +11.5% | -3.0% | +9.0% | -7.0% | +9.1% | -7.7% | -9.6% | -6.0% | +10.7% | – | |
| – | +0.4% | -5.5% | +16.4% | -2.2% | +12.7% | -0.1% | +37.8% | -26.7% | -0.6% | -2.8% | +6.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.